Labcorp Holdings Inc. LH
- Market cap
- $21.9B
- P/E
- 25.4×
Follow LH
Labcorp Holdings Inc. (LH) Return on invested capital
Labcorp Holdings Inc.'s return on invested capital over the twelve months to 30 June 2026 was 6.50%, down 0.0 percentage points from fiscal 2025 (6.54%). Over the past ten years it has ranged from 3.95% (fiscal 2023) to 13.3% (fiscal 2021); the current reading is higher than 64% of that period. That is above the Diagnostics & Research industry median of 0.00% and above the Healthcare sector median of 0.00%.
Return on invested capital, annual
Annual
| Period | Return on invested capital | Change (points) |
|---|---|---|
| FY2025 | 6.54% | 0.85 |
| FY2024 | 5.69% | 1.74 |
| FY2023 | 3.95% | (2.08) |
| FY2022 | 6.03% | (7.29) |
| FY2021 | 13.3% | 2.10 |
| FY2020 | 11.2% | 4.88 |
| FY2019 | 6.34% | (0.24) |
| FY2018 | 6.58% | 0.22 |
| FY2017 | 6.36% | (1.30) |
| FY2016 | 7.66% | 1.53 |
Against its own ten years
Return on invested capital against peers
| Company | Return on invested capital |
|---|---|
| MTD Mettler-Toledo International, Inc. compare | 35.4% |
| DGX Quest Diagnostics Incorporated compare | 7.94% |
| LH Labcorp Holdings Inc. | 6.50% |
| RVTY Revvity Inc. compare | 2.38% |
| ICLR ICON PLC compare | 1.57% |
| CRL Charles River Laboratories International, Inc. compare | 1.07% |
| MEDP Medpace Holdings, Inc. compare | 0.00% |
| TWST Twist Bioscience Corporation compare | −30.8% |
| GH Guardant Health, Inc. compare | −129.7% |
| Diagnostics & Research industry median | 0.00% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Return on invested capital is
Return on Invested Capital shows how much after-tax operating profit a company earns on the money its lenders and shareholders have put in.
TTM: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) (latest quarter) + Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter) − Cash & Short Term Investments (latest quarter)); Annual: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) + Long Term Debt (Total) + Current Part of Debt − Cash & Short Term Investments)
More on LH
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement